Search Results - "SAMUEL, CHRISHAN S."

Refine Results
  1. 1
  2. 2
  3. 3

    Inflammasomes-A Molecular Link for Altered Immunoregulation and Inflammation Mediated Vascular Dysfunction in Preeclampsia by Murthi, Padma, Pinar, Anita A, Dimitriadis, Evdokia, Samuel, Chrishan S

    “…Preeclampsia (PE) is a pregnancy-specific multisystem disorder and is associated with maladaptation of the maternal cardiovascular system and abnormal…”
    Get full text
    Journal Article
  4. 4

    Immune Mechanisms and Related Targets for the Treatment of Fibrosis in Various Organs by Pinar, Anita A, Samuel, Chrishan S

    Published in Current molecular medicine (01-01-2022)
    “…Inflammation and fibrosis are two interrelated disease pathologies with several overlapping components. Three specific cell types, namely macrophages, T helper…”
    Get more information
    Journal Article
  5. 5

    Anti-inflammatory effects of adult stem cells in sustained lung injury: a comparative study by Moodley, Yuben, Vaghjiani, Vijesh, Chan, James, Baltic, Svetlana, Ryan, Marisa, Tchongue, Jorge, Samuel, Chrishan S, Murthi, Padma, Parolini, Ornella, Manuelpillai, Ursula

    Published in PloS one (01-08-2013)
    “…Lung diseases are a major cause of global morbidity and mortality that are treated with limited efficacy. Recently stem cell therapies have been shown to…”
    Get full text
    Journal Article
  6. 6

    Enhancing the Therapeutic Potential of Mesenchymal Stromal Cell-Based Therapies with an Anti-Fibrotic Agent for the Treatment of Chronic Kidney Disease by Li, Yifang, Ricardo, Sharon D, Samuel, Chrishan S

    “…Chronic kidney disease (CKD) affects 1 in 10 members of the general population, placing these patients at an increasingly high risk of kidney failure. Despite…”
    Get full text
    Journal Article
  7. 7

    Human Umbilical Cord Mesenchymal Stem Cells Reduce Fibrosis of Bleomycin-Induced Lung Injury by Moodley, Yuben, Atienza, Daniel, Manuelpillai, Ursula, Samuel, Chrishan S, Tchongue, Jorge, Ilancheran, Sivakami, Boyd, Richard, Trounson, Alan

    Published in The American journal of pathology (01-07-2009)
    “…Acute respiratory distress syndrome is characterized by loss of lung tissue as a result of inflammation and fibrosis. Augmenting tissue repair by the use of…”
    Get full text
    Journal Article
  8. 8

    Relaxin Inhibits the Cardiac Myofibroblast NLRP3 Inflammasome as Part of Its Anti-Fibrotic Actions via the Angiotensin Type 2 and ATP (P2X7) Receptors by Tapia Cáceres, Felipe, Gaspari, Tracey A., Hossain, Mohammed Akhter, Samuel, Chrishan S.

    “…Chronic NLRP3 inflammasome activation can promote fibrosis through its production of interleukin (IL)-1β and IL-18. Conversely, recombinant human relaxin (RLX)…”
    Get full text
    Journal Article
  9. 9

    Serelaxin enhances the therapeutic effects of human amnion epithelial cell‐derived exosomes in experimental models of lung disease by Royce, Simon G., Patel, Krupesh P., Mao, WeiYi, Zhu, Dandan, Lim, Rebecca, Samuel, Chrishan S.

    Published in British journal of pharmacology (01-07-2019)
    “…Background and Purpose There is growing interest in stem cell‐derived exosomes for their therapeutic and regenerative benefits given their manufacturing and…”
    Get full text
    Journal Article
  10. 10

    IL-4 and IL-13 induce equivalent expression of traditional M2 markers and modulation of reactive oxygen species in human macrophages by Scott, Tara E., Lewis, Caitlin V., Zhu, Mingyu, Wang, Chao, Samuel, Chrishan S., Drummond, Grant R., Kemp-Harper, Barbara K.

    Published in Scientific reports (10-11-2023)
    “…In cardiovascular disease, pathological and protective roles are reported for the Th2 cytokines IL-4 and IL-13, respectively. We hypothesised that differential…”
    Get full text
    Journal Article
  11. 11

    A Lipidated Single-B-Chain Derivative of Relaxin Exhibits Improved In Vitro Serum Stability without Altering Activity by Praveen, Praveen, Wang, Chao, Handley, Thomas N G, Wu, Hongkang, Samuel, Chrishan S, Bathgate, Ross A D, Hossain, Mohammed Akhter

    “…Human relaxin-2 (H2 relaxin) is therapeutically very important due to its strong anti-fibrotic, vasodilatory, and cardioprotective effects. Therefore,…”
    Get full text
    Journal Article
  12. 12

    Human mesenchymal stem cells alter macrophage phenotype and promote regeneration via homing to the kidney following ischemia-reperfusion injury by Wise, Andrea F, Williams, Timothy M, Kiewiet, Mensiena B G, Payne, Natalie L, Siatskas, Christopher, Samuel, Chrishan S, Ricardo, Sharon D

    “…Mesenchymal stem cells (MSCs) ameliorate injury and accelerate repair in many organs, including the kidney, although the reparative mechanisms and interaction…”
    Get more information
    Journal Article
  13. 13
  14. 14

    Intranasal administration of mesenchymoangioblast‐derived mesenchymal stem cells abrogates airway fibrosis and airway hyperresponsiveness associated with chronic allergic airways disease by Royce, Simon G., Rele, Siddharth, Broughton, Brad R. S., Kelly, Kilian, Samuel, Chrishan S.

    Published in The FASEB journal (01-09-2017)
    “…ABSTRACT Structural changes known as airway remodeling (AWR) characterize chronic/severe asthma and contribute to lung dysfunction. Thus, we assessed the in…”
    Get full text
    Journal Article
  15. 15

    Relaxin requires the angiotensin II type 2 receptor to abrogate renal interstitial fibrosis by Chow, Bryna S Man, Kocan, Martina, Bosnyak, Sanja, Sarwar, Mohsin, Wigg, Belinda, Jones, Emma S, Widdop, Robert E, Summers, Roger J, Bathgate, Ross A D, Hewitson, Tim D, Samuel, Chrishan S

    Published in Kidney international (01-07-2014)
    “…Fibrosis is a hallmark of chronic kidney disease, for which there is currently no effective cure. The hormone relaxin is emerging as an effective antifibrotic…”
    Get more information
    Journal Article
  16. 16

    Relaxin signals through a RXFP1-pERK-nNOS-NO-cGMP-dependent pathway to up-regulate matrix metalloproteinases: the additional involvement of iNOS by Chow, Bryna Suet Man, Chew, Elaine Guo Yan, Zhao, Chongxin, Bathgate, Ross A D, Hewitson, Tim D, Samuel, Chrishan S

    Published in PloS one (22-08-2012)
    “…The hormone, relaxin, inhibits aberrant myofibroblast differentiation and collagen deposition by disrupting the TGF-β1/Smad2 axis, via its cognate receptor,…”
    Get full text
    Journal Article
  17. 17

    Induced pluripotent stem cell-derived mesenchymal stem cells reverse bleomycin-induced pulmonary fibrosis and related lung stiffness by Chakraborty, Amlan, Wang, Chao, Hodgson-Garms, Margeaux, Broughton, Brad R.S., Frith, Jessica E., Kelly, Kilian, Samuel, Chrishan S.

    Published in Biomedicine & pharmacotherapy (01-09-2024)
    “…Idiopathic pulmonary fibrosis (IPF) is characterised by lung scarring and stiffening, for which there is no effective cure. Based on the immunomodulatory and…”
    Get full text
    Journal Article
  18. 18

    Relaxin Can Mediate Its Anti-Fibrotic Effects by Targeting the Myofibroblast NLRP3 Inflammasome at the Level of Caspase-1 by Pinar, Anita A, Yuferov, Alexander, Gaspari, Tracey A, Samuel, Chrishan S

    Published in Frontiers in pharmacology (04-08-2020)
    “…The NLRP3 inflammasome produces interleukin (IL)-1β and IL-18, which when chronically activated by transforming growth factor (TGF)-β1, contribute to fibrosis…”
    Get full text
    Journal Article
  19. 19
  20. 20

    The Novel AT2 Receptor Agonist β-Pro7-AngIII Exerts Cardiac and Renal Anti-Fibrotic and Anti-Inflammatory Effects in High Salt-Fed Mice by Wang, Yan, Yodgee, Jonathan, Del Borgo, Mark, Spizzo, Iresha, Nguyen, Levi, Aguilar, Marie-Isabel, Denton, Kate M, Samuel, Chrishan S, Widdop, Robert E

    “…A high salt (HS) diet is associated with an increased risk for cardiovascular diseases (CVDs) and fibrosis is a key contributor to the organ dysfunction…”
    Get full text
    Journal Article